comparemela.com

Latest Breaking News On - Antoni bayes genis - Page 1 : comparemela.com

Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells

Clinical trial: First cardiac bioimplants for treatment of myocardial infarction using umbilical cord stem cells
medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.

Researchers find that targeting immune cells may help treat atrial fibrillation: New study finds that macrophages and macrophage-produced proteins contribute to heartbeat irregularities

Researchers find that targeting immune cells may help treat atrial fibrillation: New study finds that macrophages and macrophage-produced proteins contribute to heartbeat irregularities
sciencedaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sciencedaily.com Daily Mail and Mail on Sunday newspapers.

Macrophages may play a major role in the development of atrial fibrillation

Current treatments for atrial fibrillation (AFib), a common heart condition characterized by fast and irregular beats that can lead to stroke and heart failure, have multiple side effects and are ineffective for preventing AFib recurrence.

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF

Congestion Biomarker CA125 Signals Worse Outcomes in Ambulatory HFrEF
tctmd.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tctmd.com Daily Mail and Mail on Sunday newspapers.

Improving Outcomes for all Patients with Heart Failure

Improving Outcomes for all Patients with Heart Failure
dicardiology.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dicardiology.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.